Skip to main content
Albert Lockhart, MD, Oncology, Charleston, SC

Albert C Lockhart MD

Gastrointestinal Cancer, Hematologic Oncology


Associate Professor, Internal Medicine, Washington University in St. Louis School of Medicine

Join to View Full Profile
  • 171 Ashley AveCharleston, SC 29425

  • Phone+1 843-792-1414

  • Fax+1 305-243-9161

Dr. Lockhart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1997 - 2000
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1993 - 1996
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1993

Certifications & Licensure

  • SC State Medical License
    SC State Medical License 2021 - 2025
  • FL State Medical License
    FL State Medical License 2017 - 2023
  • MO State Medical License
    MO State Medical License 2008 - 2018
  • TN State Medical License
    TN State Medical License 2001 - 2010
  • NC State Medical License
    NC State Medical License 1999 - 2003
  • TX State Medical License
    TX State Medical License 1995 - 2001
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • US Patent for Cannabis-Derived Drug to Treat Eye Diseases
    US Patent for Cannabis-Derived Drug to Treat Eye DiseasesMay 22nd, 2019
  • Lowe’s Flavocure Secures US Patent for Ganja Eye Drug
    Lowe’s Flavocure Secures US Patent for Ganja Eye DrugMay 17th, 2019
  • $10.4 Million Awarded for Pancreatic Cancer Research
    $10.4 Million Awarded for Pancreatic Cancer ResearchAugust 15th, 2016

Grant Support

  • Medical University of South Carolina NCORP Minority/Underserved Community SiteMEDICAL UNIVERSITY OF SOUTH CAROLINA2014–2025
  • Pharmacogenomically Selected Treatment For Gastric And Gastroesophageal JunctionNational Cancer Institute2008
  • Genetic Polymorphisms Affecting Chemotherapy DispositionNational Cancer Institute2008
  • Genetic Polymorphisms Affecting Chemotherapy DispositionNational Cancer Institute2004–2008
  • Pharmacogenomically Selected Treatment For Gastric And Gastroesophageal JunctionNational Cancer Institute2007
  • Response To Paclitaxel Related To Genitic Variatins In MDR1National Center For Research Resources2006
  • Correlation On The Pharmacokinetics And Toxicity Of CPT-11 With FunctionallyNational Center For Research Resources2005–2006

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: